UAMS Experts Present Leukemia, Lymphoma ‘State of the Science’ Summit Oct. 13 in Little Rock

By Marty Trieschmann

To register, visit onclive.com/events.

The meeting sponsored by Oncology Live is chaired by Muthu Veeraputhiran, M.D., medical oncologist and clinical program director of stem cell transplantation and cellular therapy at the UAMS Winthrop P. Rockefeller Cancer Institute. Presenters will include Akash Murkherjee, M.D., and Cesar Sanchez, M.D., both hematologist/oncologists at the Cancer Institute.

The meeting topics will include:

  • Treating Chronic Lymphocytic Leukemia with Bruton Tyrosine Kinase inhibitors
  • Mantle Cell Lymphoma management
  • Chimeric Antigen Receptor (CAR) T-cell treatment
  • Paroxysmal Nocturnal Hemoglobinuria treatment
  • Live Q&A

 

UAMS is the state's only health sciences university, with colleges of Medicine, Nursing, Pharmacy, Health Professions and Public Health; a graduate school; a hospital; a main campus in Little Rock; a Northwest Arkansas regional campus in Fayetteville; a statewide network of regional campuses; and seven institutes: the Winthrop P. Rockefeller Cancer Institute, Jackson T. Stephens Spine & Neurosciences Institute, Harvey & Bernice Jones Eye Institute, Psychiatric Research Institute, Donald W. Reynolds Institute on Aging, Translational Research Institute and Institute for Digital Health & Innovation. UAMS includes UAMS Health, a statewide health system that encompasses all of UAMS' clinical enterprise. UAMS is the only adult Level 1 trauma center in the state. UAMS has 3,047 students, 873 medical residents and fellows, and six dental residents. It is the state's largest public employer with more than 11,000 employees, including 1,200 physicians who provide care to patients at UAMS, its regional campuses, Arkansas Children's, the VA Medical Center and Baptist Health. Visit www.uams.edu or uamshealth.com. Find us on Facebook, Twitter, YouTube or Instagram.

###